ADMA Biologics Inc

ADMA

$15.42

Name : ADMA Biologics Inc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $3,679,685,632.00

EPSttm : 0.86

ADMA Biologics Inc

$15.42

0.90%

$0.14

Float Short %

7.24

Margin Of Safety %

-4

Put/Call OI Ratio

0.32

EPS Next Q Diff

0.04

EPS Last/This Y

-0.25

EPS This/Next Y

0.36

Price

15.41

Target Price

30.67

Analyst Recom

Performance Q

-11.58

Relative Volume

0.66

Beta

0.45

Ticker: ADMA

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	ADMA	14.69	0.31	0.17	113677
2025-10-21	ADMA	14.72	0.31	0.05	114864
2025-10-22	ADMA	15.18	0.31	0.04	115319
2025-10-23	ADMA	15.24	0.31	0.06	115414
2025-10-24	ADMA	15.18	0.31	0.03	115555
2025-10-27	ADMA	15.61	0.29	0.08	122632
2025-10-28	ADMA	15.6	0.29	0.05	123264
2025-10-29	ADMA	15.52	0.29	0.35	124184
2025-10-30	ADMA	15.27	0.29	0.08	124246
2025-10-31	ADMA	15.48	0.29	0.32	124574
2025-11-03	ADMA	15.35	0.29	0.24	124704
2025-11-04	ADMA	14.62	0.29	0.02	125832
2025-11-05	ADMA	15.31	0.28	0.45	126754
2025-11-06	ADMA	14.02	0.33	0.79	156469
2025-11-07	ADMA	14.52	0.35	0.51	153627
2025-11-10	ADMA	14.72	0.34	4.34	153603
2025-11-11	ADMA	16.05	0.31	1.57	151953
2025-11-12	ADMA	16.48	0.33	0.34	153330
2025-11-13	ADMA	15.71	0.33	1.15	153637
2025-11-14	ADMA	15.56	0.33	0.91	153743
2025-11-17	ADMA	15.42	0.32	0.24	149773
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	ADMA	14.69	3.3	-	0.56
2025-10-21	ADMA	14.72	3.3	-	0.56
2025-10-22	ADMA	15.16	3.3	-	0.56
2025-10-23	ADMA	15.24	3.3	-	0.56
2025-10-24	ADMA	15.17	3.3	-	0.56
2025-10-27	ADMA	15.61	3.3	-	0.56
2025-10-28	ADMA	15.57	3.3	-	0.56
2025-10-29	ADMA	15.54	3.3	-	0.56
2025-10-30	ADMA	15.27	3.3	-	0.56
2025-10-31	ADMA	15.47	3.3	-	0.56
2025-11-03	ADMA	15.36	3.3	-	0.56
2025-11-04	ADMA	14.62	3.3	-	0.56
2025-11-05	ADMA	15.32	3.3	-	0.56
2025-11-06	ADMA	14.03	3.3	-	0.56
2025-11-07	ADMA	14.52	3.3	-	0.56
2025-11-10	ADMA	14.71	32.4	-	0.56
2025-11-11	ADMA	16.03	43.4	-	0.59
2025-11-12	ADMA	16.48	43.4	-	0.59
2025-11-13	ADMA	15.70	43.4	-	0.59
2025-11-14	ADMA	15.56	43.4	-	0.59
2025-11-17	ADMA	15.41	43.4	-	0.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	ADMA	-6.51	2.98	7.56
2025-10-21	ADMA	-6.51	2.98	7.56
2025-10-22	ADMA	-6.51	2.98	7.56
2025-10-23	ADMA	-6.51	2.98	7.56
2025-10-24	ADMA	-6.51	2.98	7.56
2025-10-27	ADMA	-6.73	-0.13	7.62
2025-10-28	ADMA	-6.73	-0.13	7.62
2025-10-29	ADMA	-6.73	-0.13	7.62
2025-10-30	ADMA	-6.73	-0.13	7.62
2025-10-31	ADMA	-6.73	-0.13	7.62
2025-11-03	ADMA	-6.75	1.32	7.62
2025-11-04	ADMA	-6.75	1.32	7.62
2025-11-05	ADMA	-6.75	1.32	7.62
2025-11-06	ADMA	-6.75	1.32	7.62
2025-11-07	ADMA	-6.75	1.32	7.62
2025-11-10	ADMA	-6.77	-0.34	7.64
2025-11-11	ADMA	-6.77	-0.34	7.64
2025-11-12	ADMA	-6.77	-0.34	7.24
2025-11-13	ADMA	-6.77	-0.34	7.24
2025-11-14	ADMA	-6.77	-0.34	7.24
2025-11-17	ADMA	-6.59	0.60	7.24
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.16

Avg. EPS Est. Current Quarter

0.2

Avg. EPS Est. Next Quarter

0.2

Insider Transactions

-6.59

Institutional Transactions

0.6

Beta

0.45

Average Sales Estimate Current Quarter

139

Average Sales Estimate Next Quarter

145

Fair Value

14.75

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-63.1

Target Price

30.67

P/E

18.11

Forward P/E

16.88

PEG

0.47

P/S

7.51

P/B

8.52

P/Free Cash Flow

90.1

EPS

0.85

Average EPS Est. Cur. Y

0.59

EPS Next Y. (Est.)

0.96

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

42.87

Relative Volume

0.66

Return on Equity vs Sector %

21.6

Return on Equity vs Industry %

36.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

ADMA Biologics Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 685

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

stock quote shares ADMA – Adma Biologics Inc Stock Price stock today

news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ADMA – Adma Biologics Inc yahoo finance google finance

stock history ADMA – Adma Biologics Inc invest stock market

stock prices ADMA premarket after hours

ticker ADMA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ADMA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y